140 related articles for article (PubMed ID: 23856823)
21. Meta-analysis of (11)C-choline and (18)F-choline PET/CT for management of patients with prostate cancer.
von Eyben FE; Kairemo K
Nucl Med Commun; 2014 Mar; 35(3):221-30. PubMed ID: 24240194
[TBL] [Abstract][Full Text] [Related]
22. ¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients.
D'Angelillo RM; Sciuto R; Ramella S; Papalia R; Jereczek-Fossa BA; Trodella LE; Fiore M; Gallucci M; Maini CL; Trodella L
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):296-302. PubMed ID: 25084612
[TBL] [Abstract][Full Text] [Related]
23. Incidental possible diagnosis by 18F-fluorocholine PET/CT of Meckel's diverticulum and potential pitfalls.
Khor LK; Loi HY; Sinha AK; Lu SJ
Hell J Nucl Med; 2015; 18(2):157-9. PubMed ID: 26187217
[TBL] [Abstract][Full Text] [Related]
24. ¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
Koo PJ; David Crawford E
Oncology (Williston Park); 2014 Dec; 28(12):1057-62, 1064-5. PubMed ID: 25738199
[TBL] [Abstract][Full Text] [Related]
25. [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
García Vicente AM; Núñez García A; Soriano Castrejón AM; Jiménez Londoño GA; Cordero García JM; Palomar Muñoz A
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):37-9. PubMed ID: 23177342
[TBL] [Abstract][Full Text] [Related]
26. Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancer.
Souvatzoglou M; Krause BJ; Pürschel A; Thamm R; Schuster T; Buck AK; Zimmermann F; Molls M; Schwaiger M; Geinitz H
Radiother Oncol; 2011 May; 99(2):193-200. PubMed ID: 21620494
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
DeGrado TR; Coleman RE; Wang S; Baldwin SW; Orr MD; Robertson CN; Polascik TJ; Price DT
Cancer Res; 2001 Jan; 61(1):110-7. PubMed ID: 11196147
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of 18F choline PET/CT using time-of-flight reconstruction algorithm in prostate cancer patients with biochemical recurrence.
Hausmann D; Bittencourt LK; Attenberger UI; Sertdemir M; Weidner A; Büsing KA; Brade J; Wenz F; Schoenberg SO; Dinter DJ
Clin Nucl Med; 2014 Mar; 39(3):e197-201. PubMed ID: 24092230
[TBL] [Abstract][Full Text] [Related]
29. Incidental detection of Hürthle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer.
Paone G; Treglia G; Bongiovanni M; Ruberto T; Ceriani L; Giovanella L
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):340-1. PubMed ID: 23796426
[No Abstract] [Full Text] [Related]
30. Incidental finding of parathyroid adenoma with 11C-choline PET/CT.
Mapelli P; Busnardo E; Magnani P; Freschi M; Picchio M; Gianolli L; Messa C
Clin Nucl Med; 2012 Jun; 37(6):593-5. PubMed ID: 22614195
[TBL] [Abstract][Full Text] [Related]
31. [11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma.
Reske SN; Moritz S; Kull T
Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):430-9. PubMed ID: 23069922
[TBL] [Abstract][Full Text] [Related]
32. Squamous cell carcinoma of the tonsil incidentally detected by 18F-choline PET/CT.
Treglia G; Ceriani L; Barizzi J; Bertagna F; Giovanella L
Clin Nucl Med; 2015 Jan; 40(1):93-5. PubMed ID: 24662666
[TBL] [Abstract][Full Text] [Related]
33. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
[TBL] [Abstract][Full Text] [Related]
34. [18F]choline positron emission tomography in prostate cancer patients with biochemical recurrence after radical prostatectomy: influence of antiandrogen therapy - a preliminary study.
Henninger B; Vesco P; Putzer D; Kendler D; Loizides A; Bale RJ; Virgolini IJ
Nucl Med Commun; 2012 Aug; 33(8):889-94. PubMed ID: 22692582
[TBL] [Abstract][Full Text] [Related]
35. ¹¹C-Choline PET/CT in Recurrent Prostate Cancer and Nonprostatic Neoplastic Processes.
Welle CL; Cullen EL; Peller PJ; Lowe VJ; Murphy RC; Johnson GB; Binkovitz LA
Radiographics; 2016; 36(1):279-92. PubMed ID: 26761541
[TBL] [Abstract][Full Text] [Related]
36. F-18 FDG PET/CT imaging of a Leydig cell tumor.
Lee G; Lee JH; Lee WA
Clin Nucl Med; 2010 Mar; 35(3):202-4. PubMed ID: 20173460
[TBL] [Abstract][Full Text] [Related]
37. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography.
Kwee SA; Coel MN; Lim J; Ko JP
J Urol; 2005 Jan; 173(1):252-5. PubMed ID: 15592091
[TBL] [Abstract][Full Text] [Related]
38. Optimized protocol for (18)F-choline PET/CT in patients with biochemically relapsed prostate cancer: experiences on 250 consecutive cases.
Chondrogiannis S; Marzola MC; Grassetto G; Rampin L; Massaro A; Colletti PM; Rubello D
Clin Nucl Med; 2015 Jun; 40(6):e308-12. PubMed ID: 25742236
[TBL] [Abstract][Full Text] [Related]
39. Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake.
Balogova S; Huchet V; Egrot C; Michaud L; Paycha F; Kerrou K; Montravers F; Cussenot O; Talbot JN
Clin Nucl Med; 2013 Mar; 38(3):200-2. PubMed ID: 23354033
[TBL] [Abstract][Full Text] [Related]
40. Choline PET/CT for imaging prostate cancer: an update.
Kitajima K; Murphy RC; Nathan MA
Ann Nucl Med; 2013 Aug; 27(7):581-91. PubMed ID: 23632880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
